Uncategorized
- Neuroscience
FDA advisory panel declines to support a controversial Alzheimer’s treatment
The fate of an Alzheimer’s drug, developed by pharmaceutical company Biogen, remains up in the air.
-
-
In praise of serendipity — and scientific obsession
Editor in chief Nancy Shute writes about the role of serendipity and scientific obsession played in this month's feature stories.
- Tech
A smartwatch app alerts users with hearing loss to nearby sounds
With a new smartwatch app, users who are deaf or hard of hearing can get alerts that an alarm is going off or someone is knocking at the door.
